Concepts (43)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 8 | 2025 | 894 | 1.500 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2025 | 146 | 1.230 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 10 | 0.710 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 2025 | 503 | 0.690 |
Why?
|
| Fibrinogen | 1 | 2021 | 163 | 0.670 |
Why?
|
| Anaphylaxis | 1 | 2021 | 86 | 0.640 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 141 | 0.620 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 177 | 0.620 |
Why?
|
| Hypersensitivity | 1 | 2021 | 194 | 0.600 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 699 | 0.490 |
Why?
|
| Neoplasms | 1 | 2022 | 3037 | 0.270 |
Why?
|
| Antigens, CD19 | 1 | 2022 | 181 | 0.180 |
Why?
|
| T-Lymphocytes | 4 | 2024 | 1814 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2025 | 753 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2025 | 567 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 1012 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 265 | 0.130 |
Why?
|
| Adolescent | 6 | 2025 | 20601 | 0.130 |
Why?
|
| Child | 7 | 2025 | 25843 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 453 | 0.120 |
Why?
|
| Humans | 11 | 2025 | 134085 | 0.120 |
Why?
|
| Patient Safety | 1 | 2019 | 433 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2019 | 737 | 0.110 |
Why?
|
| Young Adult | 5 | 2025 | 9917 | 0.110 |
Why?
|
| Prognosis | 1 | 2021 | 5085 | 0.090 |
Why?
|
| Recurrence | 2 | 2025 | 1472 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2025 | 14838 | 0.080 |
Why?
|
| Male | 6 | 2025 | 66057 | 0.070 |
Why?
|
| Female | 6 | 2025 | 71851 | 0.070 |
Why?
|
| Adult | 5 | 2025 | 31964 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6305 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2025 | 342 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2025 | 13051 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2025 | 370 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2023 | 202 | 0.050 |
Why?
|
| Registries | 1 | 2025 | 1577 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 377 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 29402 | 0.030 |
Why?
|
| Genomics | 1 | 2019 | 1669 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13201 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3729 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 11166 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21756 | 0.020 |
Why?
|